반응식
[N:1]1([S:6](Cl)(=[O:8])=[O:7])[CH2:5][CH2:4][CH2:3][CH2:2]1.[C:10]([O:14][C:15]([N:17]1[C:25]2[C:20](=[CH:21][CH:22]=[C:23]([Cl:26])[CH:24]=2)[CH:19]=[C:18]1[C:27]1[CH:28]=[N:29][CH:30]=[C:31]([OH:33])[CH:32]=1)=[O:16])([CH3:13])([CH3:12])[CH3:11]>>[C:10]([O:14][C:15]([N:17]1[C:25]2[C:20](=[CH:21][CH:22]=[C:23]([Cl:26])[CH:24]=2)[CH:19]=[C:18]1[C:27]1[CH:28]=[N:29][CH:30]=[C:31]([O:33][S:6]([N:1]2[CH2:5][CH2:4][CH2:3][CH2:2]2)(=[O:8])=[O:7])[CH:32]=1)=[O:16])([CH3:13])([CH3:11])[CH3:12]참가 물질
3
실험 절차
1-Pyrrolidine-sulfonyl chloride and 6-chloro-2-(5-hydroxy-pyridin-3-yl)-indole-1-carboxylic acid tert-butyl ester (Example 160a) are processed according to the method described in Example 160b to give 6-chloro-2-[5-(pyrrolidine-1-sulfonyloxy)-pyridin-3-yl]-indole-1-carboxylic acid tert-butyl ester, which is taken onto the next step without further purification. MS (ESI) m/z 478.1 (M+H)+.
출처 및 근거
- ORD 기록
- ord-b0284560b9f64148950560c56d05a055
- 출처 데이터셋
- uspto-grants-2016_01
- 특허 번호
- US09242963B2
연결된 노트
불러오는 중…